SCHEMBL8977487

SCHEMBL8977487

CC(C)(C)OC(=O)NC(C(=O)O)c1ccc2nc(N)sc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
SCN4A P35499 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
LIPG Q9Y5X9 1/20 0.43
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
KIT P10721 1/20 0.41
CYP3A4 P08684 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PIK3CA P42336 1/20 0.40
LCK P06239 3/20 0.39
CYP2D6 P10635 2/20 0.39
KCNH2 Q12809 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9619945 0.91 CTSS (0.38) RAB9ANPC1SCN4ASMN1; SMN2LIPG
SCHEMBL8977464 0.86 LCK (0.54) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL9620030 0.80 CYP3A4 (0.51) RAB9ANPC1SCN4ASMN1; SMN2ALDH1A1
SCHEMBL9844859 0.80 NPC1 (0.43) RAB9ANPC1SCN4ASMN1; SMN2ALDH1A1
SCHEMBL9364669 0.80 IRAK4 (0.43) RAB9ANPC1LMNAL3MBTL1
SCHEMBL10627562 0.79 CTSS (0.43) RAB9ANPC1ALDH1A1MAPTGAA
SCHEMBL9648060 0.78 RAB9A (0.47) RAB9ANPC1SCN4ASMN1; SMN2ALDH1A1
SCHEMBL9364334 0.78 RAB9A (0.47) RAB9ANPC1SCN4ASMN1; SMN2ALDH1A1
SCHEMBL10926694 0.77 CTSS (0.41) MAPTGAA
SCHEMBL7130741 0.76 EPHX2 (0.58) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0195947-B1 Beta-lactam antibiotics, process for their preparation and their use as and in medicaments BAYER AG (DE) 1996-04-24 EP disclosed
EP-0292806-B1 Substituted vinyl cephalosporins, process for their preparation and their use as medicines BAYER AG (DE) 1994-11-02 EP disclosed
EP-0292808-B1 Substituted vinyl cephalosporins, process for their preparation and their use as medicines BAYER AG (DE) 1994-03-02 EP disclosed
US-5171854-A Antibiotics BAYER AKTIENGESELLSCHAFT (DE) 1992-12-15 US disclosed
US-RE33948-E Bactericides, animal growth regulators BAYER AKTIENGESELLSCHAFT (DE) 1992-06-02 US disclosed
US-4973685-A PENICILLINS AND CEPHALOSPORINS BAYER AKTIENGESELLSCHAFT (DE) 1990-11-27 US disclosed
EP-0310909-A2 Heteroannelated phenyl glycine beta-lactam antibiotics, process for their preparation and their use as therapeutical agents BAYER AG (DE) 1989-04-12 EP disclosed
EP-0292806-A2 Substituted vinyl cephalosporins, process for their preparation and their use as medicines BAYER AG (DE) 1988-11-30 EP disclosed
US-4748163-A Novel β-lactam antibiotics BAYER AKTIENGESELLSCHAFT (DE) 1988-05-31 US disclosed